US Environmental Protection Agency (EPA)

Photo
08.06.2023 • News

Out-of-Court PFAS Settlement for DuPont and Ex-units

DuPont and former group units Chemours and Corteva have agreed to pay more than $1 billion to settle out of court US claims that per- and polyfluoroalkyl substances (PFAS) discharged from their plants contaminated waterways that supply a majority of US public water systems.

Photo
02.03.2023 • News

US Orders Emissions Cuts at Denka’s Louisiana Site

Acting on behalf of the Environmental Protection Agency (EPA) and the US Attorney’s Office for the Eastern District of Louisiana, the US Department of Justice has ordered Japanese plastics and rubber producer Denka Performance Elastomer to “significantly reduce” hazardous chloroprene emissions from its neoprene plant in LaPlace, Louisiana.

Photo
26.10.2022 • News

US Ratifies Kigali Amendment to Montreal Protocol

The US Environmental Protection Agency (EPA) has announced additional actions to phase down the use of ozone-depleting hydrofluorocarbons (HFCs), lending a boost to president Joe Biden’s agenda for combating climate change.

Photo
20.04.2022 • News

EPA Investigating Louisiana Plant Permits

The US Environmental Protection Agency (EPA) is taking a closer look at permits issued for chemical plants by the state of Louisiana’s environment department (LDEQ) over several years in an effort to determine whether they violated anti-pollution standards and disadvantaged Black people residing downwind.

Photo
08.04.2021 • News

New EPA Administrator Broom Sweeps Clean

New US Environmental Protection Agency (EPA) administrator Michael Regan, sworn in to his office on Mar. 17, has begun removing experts and lobbyists from industry who were appointed by former president Donald Trump to two key advisory panels.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.